Keith Lamont Cummings - Net Worth and Insider Trading
Keith Lamont Cummings Net Worth
The estimated net worth of Keith Lamont Cummings is at least $4 Million dollars as of 2024-11-28. Keith Lamont Cummings is the CFO of Pliant Therapeutics Inc and owns about 282,115 shares of Pliant Therapeutics Inc (PLRX) stock worth over $4 Million. Details can be seen in Keith Lamont Cummings's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Keith Lamont Cummings has not made any transactions after 2024-07-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Keith Lamont Cummings
Keith Lamont Cummings Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Keith Lamont Cummings owns 1 companies in total, including Pliant Therapeutics Inc (PLRX) .
Click here to see the complete history of Keith Lamont Cummings’s form 4 insider trades.
Insider Ownership Summary of Keith Lamont Cummings
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PLRX | Pliant Therapeutics Inc | 2024-07-10 | Chief Financial Officer |
Keith Lamont Cummings Latest Holdings Summary
Keith Lamont Cummings currently owns a total of 1 stock. Keith Lamont Cummings owns 282,115 shares of Pliant Therapeutics Inc (PLRX) as of July 10, 2024, with a value of $4 Million.
Latest Holdings of Keith Lamont Cummings
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PLRX | Pliant Therapeutics Inc | 2024-07-10 | 282,115 | 13.53 | 3,817,016 |
Holding Weightings of Keith Lamont Cummings
Keith Lamont Cummings Form 4 Trading Tracker
According to the SEC Form 4 filings, Keith Lamont Cummings has made a total of 7 transactions in Pliant Therapeutics Inc (PLRX) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Pliant Therapeutics Inc is the sale of 10,911 shares on July 10, 2024, which brought Keith Lamont Cummings around $126,131.
Insider Trading History of Keith Lamont Cummings
- 1
Keith Lamont Cummings Trading Performance
Keith Lamont Cummings Ownership Network
Keith Lamont Cummings Owned Company Details
What does Pliant Therapeutics Inc do?
Who are the key executives at Pliant Therapeutics Inc?
Keith Lamont Cummings is the Chief Financial Officer of Pliant Therapeutics Inc. Other key executives at Pliant Therapeutics Inc include Chief Business Officer Hans Hull , Chief Medical Officer Eric Lefebvre , and director & President and CEO Bernard Coulie .
Pliant Therapeutics Inc (PLRX) Insider Trades Summary
Over the past 18 months, Keith Lamont Cummings made 3 insider transaction in Pliant Therapeutics Inc (PLRX) with a net sale of 40,463. Other recent insider transactions involving Pliant Therapeutics Inc (PLRX) include a net sale of 72,542 shares made by Hans Hull , a net sale of 30,386 shares made by Mike Ouimette , and a net sale of 134,581 shares made by Bernard Coulie .
In summary, during the past 3 months, insiders sold 0 shares of Pliant Therapeutics Inc (PLRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 322,907 shares of Pliant Therapeutics Inc (PLRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 322,907 shares.
Pliant Therapeutics Inc (PLRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pliant Therapeutics Inc Insider Transactions
Keith Lamont Cummings Mailing Address
Above is the net worth, insider trading, and ownership report for Keith Lamont Cummings. You might contact Keith Lamont Cummings via mailing address: C/o Pliant Therapeutics, Inc., 260 Littlefield Avenue, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
